Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Up News November 2007

Executive Summary

Noteworthy news from medtech start-ups, including Actuality Medical's dynamic adaptive therapy for brachytherapy and other indications; WaveBlend's new platform for aesthetic treatments; new spine products from US Spine.

You may also be interested in...



Actuality Medical Inc.

All cancer treatments-- surgery, chemotherapy and radiation therapy-carry the risk of adverse effects or the need for adjuvant therapies. With two-thirds of all cancer patients today receiving radiation therapy and a significant number undergoing invasive therapies such as surgery, Actuality Medical is developing technology for improving the precision, morbidity, and quality of radiation oncology and surgical excision for soft tissue applications, starting with prostate and breast cancer.

Spine Market: Are the Good Times Over?

The global market for spine implants and products will surpass $6 billion this year. While technological innovations continue to abound and industry proponents forecast sustained double-digit growth, the spine market is entering an unsettling phase of bureaucratic regulation and oversight from regulators and payors who appear intent on putting the breaks on this sector.

Orthopedics Settlement: Puts the Issue to Bed--Or Does It?

Though government officials and critics in the press painted lucrative consulting arrangements as unscrupulous tools in the hands of Big Ortho, no one's happier to see them go than the orthopedics industry itself. Here’s how the details shake out for the industry, and why executives are actually relieved to have some sticky legal and moral issues disappear. Some even predict that the end result will be lower overhead for their companies.

Related Content

Related Companies

Related Deals

UsernamePublicRestriction

Register

MT035127

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel